What Challenges Exist in Targeting Catalytic Processes for Immune Evasion?
Several challenges must be addressed to effectively target catalytic processes for immune evasion:
Specificity: Designing inhibitors or therapies that specifically target pathogenic or cancerous cells without affecting normal immune function is challenging. Resistance: Pathogens and cancer cells can develop resistance to catalytic inhibitors, necessitating the continuous development of new therapeutic strategies. Toxicity: Ensuring that catalytic inhibitors do not cause undue toxicity to the host is crucial for their therapeutic success.
